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Abstract
Background: While low-grade inflammation has consistently been observed in subjects with
depression, studies on the possible relationship between inflammation and other aspects of brain
function are as yet sparse. In this study, we aimed to investigate the possible association between
serum levels of the inflammation marker C-reactive protein (CRP) and personality traits.
Methods: In this study, serum levels of high-sensitivity CRP were determined by ELISA in a
population of 270 42-year-old women recruited from the population registry who had been
assessed using the Temperament and Character Inventory. Self-reported previous or ongoing
depression was also recorded. Unpaired two-tailed t-tests were used for comparison between two
groups and correlations were evaluated by the calculation of Pearson's r-coefficient.
Results: The temperament trait harm avoidance was positively (r = 0.227, p < 0.05) and the
character trait self-directedness was negatively (r = -0.261, p < 0.01) associated with serum levels
of CRP (p-values corrected for multiple comparisons). The correlations between the personality
traits and CRP were observed also after exclusion of subjects reporting ongoing depression (n =
26). Whereas women reporting ongoing depression showed significantly increased levels of CRP
as compared to non-depressed women (n = 155), women reporting a history of depression
displayed no significant difference in CRP levels as compared to women that reported that they had
never been depressed.
Conclusion: Serum levels of CRP in women was found to be associated with the personality traits
harm avoidance and self-directedness. In addition, moderately elevated levels may be a state
dependent marker of depression.
Background
Following the introduction of commercial assays with
high sensitivity for C-reactive protein (CRP) moderately
elevated levels of this compound in serum have become a
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well-established marker of low-grade inflammation. The
finding that depression is often associated with such an
increase in CRP – that has by now been corroborated in
several studies [1-4] – is an observation of considerable
importance, as is the recent finding that a similar aberra-
tion may be observed also in subjects with panic disorder
[5]. If this association between CRP and psychiatric mor-
bidity is a consequence of depression and anxiety influ-
encing the immune system, or if low-grade inflammation
may contribute to the development of depression or panic
disorder, however is as yet unknown. To cast further light
on why CRP is associated with depression and anxiety,
and to explore the possible relationship between this
marker of low-grade inflammation and other aspects of
behavior, including personality traits, hence are impor-
tant tasks.
The relationship between depression and panic disorder
on the one hand, and elevated levels of CRP on the other,
is rendered even more important given the well-estab-
lished but as yet unexplained relationship between these
two disorders and cardiovascular morbidity [6-14]. The
observations that enhanced CRP is an important risk fac-
tor for coronary disease [15-21], and that CRP promote
atherosclerotic processes and endothelial cell inflamma-
tion [22,23], make it tempting to suggest that low-grade
inflammation may be a factor of importance for the asso-
ciation between depression/anxiety and cardiovascular
disease.
One obvious way of enhancing our insight into the rela-
tionship between CRP and psychiatric disorders is to
explore to what extent CRP is associated also with other
aspects of brain function, including both other psychiatric
disorders and normal personality traits. Exploring the
possible relationship between personality and CRP is
motivated also by the fact that not only depression and
panic disorder, but also certain personality traits, have
been suggested to enhance the risk for cardiovascular dis-
ease [24-27].
To this end, this study was designed to explore the possi-
ble relationship between personality traits and CRP. For
the assessment of personality, the Temperament and
Character Inventory (TCI) [28] was chosen, being one of
the most widely used instruments for the assessment of
personality in current psychiatric research. The TCI is
based on a self-report questionnaire and comprises seven
dimensions, two of which have been suggested to render
the individual more prone to develop depression – harm
avoidance (being high in subjects at risk for depression)
and self-directedness (being low in these subjects) [29].
The primary question prompting this study hence was to
what extent there is an association between personality
traits as assessed using TCI on the one hand, and CRP lev-
els on the other, in non-depressed subjects, our à priori
hypothesis being that especially those personality traits
that have been shown to be associated with an enhanced
risk for depression might be associated with elevated CRP.
A rough estimate of ongoing or past depression was
obtained by means of a brief yes/no questionnaire based
on the DSM general criteria of major depression. The
study provides preliminary support for the notion that
high harm avoidance and low self-directedness are indeed
associated with elevated CRP in middle-aged women




All women born on uneven days in the year of 1956 and
living in Göteborg, Sweden, constituted the primary
cohort (n = 1137); this population-based cohort had orig-
inally been recruited for a study of obesity, anthropomet-
rics, and cardiovascular risk factors [30]. Reported self-
measurements of body weight, height, and circumference
ratio over the waist and hips (WHR), were completed and
returned by 80% of the original cohort. WHR was then
used for a selection of 450 women in total with low,
median or high WHR. Of these women, 270 (60%) volun-
teered to provide blood samples for hormone analyses. At
the time of blood sampling, collection of questionnaires
(TCI questionnaires were returned by 201 women) and an
anthropometric examination were performed recording
weight, length and WHR. The women also self-reported
smoking habits. In order to screen for previous episodes
of depression, the women were asked to answer 'yes' or
'no' on the question whether they had previously felt
depressed for a two-week period, or if they had experi-
enced loss of interest or pleasure for a two-week period.
To screen for ongoing depression, they were asked to
answer 'yes' or 'no' on the question if they now did feel
depressed or experienced a loss of interest or pleasure, and
had been doing so for at least two weeks. At the time of the
investigation the participants were 42 years old and dis-
played a body mass index (BMI) of 24.9 ± 4.4 kg/m2.
Thirty-four percent were smokers. Women using hormo-
nal contraceptives (20 women out of 201) were excluded
due to reported increased levels of CRP in users of such
substances [31-33]. Individuals with CRP ≥ 5 mg/L (n =
16) were also excluded since this may be an indicator of
an acute inflammatory response (see Determination of
CRP). Three women fulfilled both these exclusion criteria.
In total, the study regarding personality and CRP thus
comprised 168 women. Information regarding self-
reported ongoing or past depression was obtained from
216 women and after exclusion of women using hormo-
nal contraceptives and/or with CRP levels ≥ 5 mg/L, 181
women remained to be included in the investigation of a
possible association between depression and CRP; 166 ofBehavioral and Brain Functions 2008, 4:16 http://www.behavioralandbrainfunctions.com/content/4/1/16
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these women had completed the TCI questionnaire and
were part of the study regarding serum levels of CRP and
personality. All participating women gave their informed
consent and the study protocol was approved by the ethi-
cal committee of Göteborg University. The trial was car-
ried out according to the Helsinki Declaration.
Determination of CRP
Venous-blood samples were obtained between 0800 h
and 1000 h after an overnight fast in the follicular phase
of the menstrual cycle. Serum samples were stored at -
80°C until analysis four years later. CRP levels were deter-
mined by means of a high-sensitive double-antibody
ELISA purchased from Immundiagnostik A, Bensheim,
Germany. Women with elevated CRP levels (≥ 5 mg/L)
were excluded from further analysis in line with the
instructions of the manufacturer of the assay the since
such levels may be indicative of an acute inflammatory
response [34-36]. The inter-assay and intra-assay coeffi-
cients of variance were 6.0% and 0.1–4.6%, respectively.
Personality assessment
TCI is a psychometric instrument based on a self-adminis-
tered true/false questionnaire and designed to assess per-
sonality along four temperament dimensions referring to
individual differences in basic emotional responses: nov-
elty seeking (high scores imply e.g. exploratory behavior
and impulsiveness; low scores imply e.g. an indifferent or
reflective personality), harm avoidance (high scores imply
e.g. pessimistic worry and passive avoidant behavior; low
scores imply a relaxed and outgoing personality), reward
dependence (high scores imply e.g. social attachment and
dependence on approval of others; low scores imply e.g.
detachment), and persistence (high scores imply e.g.
ambition and diligence; low scores imply an inactive and
modest personality). TCI also measures three character
dimensions referring to individual differences in goals,
values, and self-conscious emotions: self-directedness
(high scores imply e.g. responsibility, purposefulness and
self-acceptance; low scores imply e.g. immaturity and hab-
its incongruent with long-term goals), cooperativeness
(high scores imply e.g. social tolerance and integration in
the society; low scores imply e.g. revengefulness and
unhelpfulness), and self-transcendence (high scores
imply e.g. imagination, wisdom and integration of uni-
verse as a whole; low scores imply e.g. impatience and lack
of humility) [28,37]. In the present study, a Swedish 238-
item translation of the TCI was used [38]. The TCI factors
and sub-dimensions were analysed using normative data.
Statistical analyses
Unpaired two-tailed t-tests were used for comparison
between two groups and all measured values are
expressed as mean ± SD. Correlations were evaluated by
the calculation of Pearson's r-coefficient; the significance
of the correlations were also controlled for the confound-
ing factors BMI and smoking. Due to multiple significance
tests, p-values were adjusted by means of the Bonferroni
correction (p-values were multiplied with the number of
TCI factors that were assessed). p-values < 0.05 were con-
sidered statistically significant.
Results
The mean serum levels of CRP in the women included in
the analysis of personality traits (n = 168) was 1.17 ± 1.19
mg/L (median level 0.63 mg/L). The TCI factors harm
avoidance and self-directedness correlated significantly
with CRP (see Table 1). After adjustment for BMI and
smoking, the correlations remained significant; with
respect to HA, they were strengthened. The correlations
Table 1: Correlations between CRP levels and temperament and character dimensions assessed by TCI (n = 168).
Correlation p-value Bonferroni corrected p-value
Novelty seeking -0.027 ns
Harm avoidance 0.227 0.003 0.02
Anticipatory worry 0.149 0.05
Fear of uncertainty 0.165 0.03
Shyness 0.185 0.02
Fatigability and asthenia 0.218 0.004
Reward dependence 0.076 ns
Persistence 0.039 ns





Congruent second nature -0.213 0.006
Cooperativeness -0.020 ns
Self-transcendence -0.043 ns
ns = non significantBehavioral and Brain Functions 2008, 4:16 http://www.behavioralandbrainfunctions.com/content/4/1/16
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between CRP, on the one hand, and harm avoidance and
self-directedness, on the other, remained significant also
after exclusion of women self-reporting ongoing depres-
sion (data not shown). When comparing women con-
firming past but not present depression (n = 71) and
women without a history of depression (n = 71), harm
avoidance did not correlate with serum levels of CRP in
either of the groups. Women reporting a history of depres-
sion (but denying ongoing depression) showed a signifi-
cant correlation between self-directedness and CRP levels
(r = -0.326, p < 0.05, corrected for multiple comparisons)
whereas the CRP levels of women never being depressed
did not significantly correlate with self-directedness (r = -
0.209, p > 0.05). When analysing the sub-dimensions of
harm avoidance, fatigability/asthenia displayed the
strongest correlation with CRP. With respect to self-direct-
edness, the sub-dimensions purposefulness and congru-
ent second nature correlated significantly with the
inflammation marker after corrections for multiple com-
parisons (see Table 1).
Women who reported that they suffered from an ongoing
depression (n = 26) displayed significantly higher levels of
CRP than women denying being depressed (n = 155):
1.69 ± 1.44 versus 1.14 ± 1.17 mg/L (p < 0.05). This dif-
ference remained significant also after exclusion of smok-
ers (data not shown). Women confirming past but not
present depression (n = 78) did not differ from women
without a history of depression (previous or ongoing) (n
= 77) regarding CRP levels (1.20 ± 1.13 versus 1.08 ± 1.13
mg/L); similar results were obtained also when analysing
smokers and non-smokers separately.
Discussion
The main finding of this paper is that the temperament
trait harm avoidance was positively, and the character trait
self-directedness negatively, associated with CRP levels in
a population-based cohort of women. In line with this
outcome, an inverse correlation between harm avoidance
and self-directedness has been observed by others [39],
and was confirmed by our data (not shown).
This is the first study examining CRP levels in subjects in
which personality traits have been assessed using the TCI.
Previous studies regarding personality traits, measured
with other instruments, versus CRP levels, also are sparse.
Proneness for anger and hostility has however been asso-
ciated with elevated levels of CRP [4,40-42]. Also, a study
regarding fear for terror attacks revealed, in women but
not in men, a positive association between fear and ele-
vated CRP levels after adjustment for generalized anxiety,
depressive symptoms and other confounding variables
[43].
Although the literature is not unanimous [44-46], a large
number of studies suggest that ongoing depression is
associated with elevated levels of CRP [1-3,47-50]. In line
with this notion, women in our study reporting ongoing
depression displayed elevated CRP levels. Since previous
studies have shown that depression is often associated
with high harm avoidance and low self-directedness state
[51-54], it might be suggested that the observed associa-
tion between these personality traits and CRP merely
reflects an underlying depression. However, the associa-
tion between personality traits and CRP was found also in
women denying ongoing depression, suggesting that
these personality traits per se are related to low-grade
inflammation, irrespectively of an ongoing depression.
Different explanations for the relationship between high
levels of CRP and depression have been put forward,
including the possibility that depression influences the
immune system, hence eliciting low-grade inflammation,
and the alternative explanation that low-grade inflamma-
tion may cause depression. The present study, indicating
that CRP may be associated with personality traits,
assumed to be relatively stable throughout life, casts new
light on this issue. Of interest in this context is however
the fact that high harm avoidance and low self-directed-
ness, i.e. the two traits displaying significant associations
with CRP in this study, are important predictors of depres-
sion [29]. One possibility would be that low-grade
inflammation may be both the result of actual or per-
ceived stress [55] – and hence associated with certain per-
sonality traits – and a cause for depression, subjects with
high harm avoidance and low self-directedness being
characterized by low-grade inflammation that may trigger
depressive episodes.
Notably, previous studies as well as our data suggest that
levels of CRP are higher during an ongoing depression
than after recovery, hence suggesting CRP to be a state
dependent rather than a trait dependent marker of depres-
sion [47]. On the other hand, the available data do not
exclude the possibility that CRP levels are slightly elevated
also after recovery, and between episodes in recurrent
depression [1,2,47].
Importantly, twin studies [56] suggest the heritability of
CRP levels to be considerable. This might reflect that the
underlying determinants of CRP formation such as obes-
ity or proneness to low-grade inflammation are heredi-
tary, but may also be the result of a more direct influence
of genes on CRP production. Several reports have thus
shown that polymorphisms in the gene coding for CRP
are associated with baseline levels of circulating CRP
[57,58]. These polymorphisms may hence be of possible
importance for the inflammatory response [59]. When
discussing possible explanations for the association withBehavioral and Brain Functions 2008, 4:16 http://www.behavioralandbrainfunctions.com/content/4/1/16
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personality traits and depressed mood on the one hand,
and CRP levels on the other, in terms of causality, the pos-
sibility that certain genes may exert a parallel influence on
CRP levels and on brain development and function
should not be excluded. The fact that genes are important
for personality traits, including those assessed by the TCI
scale [37], as well as for traits such as aggression and irri-
tability [60], is well established.
Previous studies have suggested that the apparent associa-
tion between symptoms of depression and CRP may be
partly due to a confounding variable, e.g. high BMI [44].
It is hence important to note that the association between
CRP and the traits harm avoidance and self-directedness
was not weakened by correcting for BMI or smoking. On
the other hand, it should be taken into consideration that
we did not control for other factors that may influence
CRP levels such as diet [61], exercise [62], and socioeco-
nomic status [63]. In order to exclude individuals with an
acute infection or inflammation and avoid false high lev-
els of CRP women with CRP levels exceeding 5 mg/L were
excluded. However, the acute phase response is a contin-
uum and no true normal range for CRP levels is estab-
lished. It has been suggested that levels below
approximately 3 mg/L represent "normal" values and CRP
levels above 10 mg/L reflect a clinically significant inflam-
matory state [35,64]. Since blood samples were obtained
once only, it cannot be excluded that high levels in some
subjects were the results of an ongoing infection or
inflammation.
CRP being associated with certain personality traits, and,
at the same time, being an important risk factor for cardi-
ovascular disease, makes it tempting to suggest that it may
serve as a mediator between these two variables. The TCI
sub-dimensions that most clearly correlated with CRP, i.e.
fatigability/asthenia and purposefulness, may be factors
predisposing individuals to burnout, a state characterized
by emotional exhaustion and feelings of inadequate con-
trol over one's job [for refs, see [65]]. Burnout has been
associated with microinflammation [66] as well as with
cardiovascular disease [67,68] also after controlling for
depression and other confounding variables. Interest-
ingly, CRP has been suggested to directly influence athero-
sclerosis [22,23]. A speculative interpretation of our study
would be that women being confident, optimistic and
self-sufficient, by displaying lower levels of CRP, also may
exhibit a decreased risk for cardiovascular disease. This
suggestion is well in line with previous studies [69-71].
Limitations of this study are that the number of assessed
subjects was relatively small, and that the presented asso-
ciations, though significant, were modest in term of r-val-
ues. The population was recruited by means of population
register, but the fact that the participants had accepted to
participate may render a group somewhat non-represent-
ative for the general population. A strength of the study is
that all studied subjects were of the same gender and age,
hence reducing age- and sex-related sources of variability,
and that all blood samples taken for analyses of CRP lev-
els were obtained in the same (follicular) phase of the
menstrual cycle [72]. At the same time, the homogeneity
of the group with respect to sex and age obviously limits
the possibility to draw more generalised conclusions from
the results, and makes further studies investigating the
relationship between levels of CRP and personality traits
in women at other ages and in men highly warranted.
Another important limitation of the study is that depres-
sion was not assessed using a structured interview, but
only by means of a few questions. Previous studies how-
ever suggest that very brief depression questionnaires,
comprising only a couple of questions, such as the one
used in this trial, do display an acceptable sensitivity
[73,74]; there are hence reasons to believe that the obser-
vation of a relationship between personality traits and
CRP in the non-depressed group is not largely influenced
by the erroneous inclusion of depressed subjects in this
analysis. Also, the self-reported rate of depression in this
female population is well in line with other reports [75].
This notwithstanding, the results should be regarded as
preliminary until replicated in women evaluated by a
more comprehensive depression questionnaire, or, prefer-
ably, by a structured interview.
Conclusion
In this study, the personality trait harm avoidance was
positively, and the character trait self-directedness nega-
tively, associated with serum CRP levels in women. Previ-
ously published studies [76] have suggested that type D
personality, described as a synergy between negative affec-
tivity and social inhibition, is an important risk factor for
morbidity and mortality in patients suffering from cardi-
ovascular disease. In this respect it is tempting to suggest
that one link between psychological distress and cardio-
vascular disease may be raised levels of CRP. The underly-
ing mechanism behind the association between brain
functions and peripheral low-grade inflammation, also
demonstrated in ongoing depression, however remains
unknown.
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